Barclays’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-8
| Closed | – | – | 4488 |
|
2024
Q2 | $0 | Sell |
8
-11,348
| -100% | – | ﹤0.01% | 4361 |
|
2024
Q1 | $27K | Sell |
11,356
-10,905
| -49% | -$25.9K | ﹤0.01% | 3920 |
|
2023
Q4 | $45K | Buy |
22,261
+19,434
| +687% | +$39.3K | ﹤0.01% | 3862 |
|
2023
Q3 | $14K | Sell |
2,827
-401
| -12% | -$1.99K | ﹤0.01% | 3978 |
|
2023
Q2 | $22K | Sell |
3,228
-4,088
| -56% | -$27.9K | ﹤0.01% | 3956 |
|
2023
Q1 | $53K | Buy |
7,316
+3,428
| +88% | +$24.8K | ﹤0.01% | 3776 |
|
2022
Q4 | $50K | Buy |
3,888
+3,274
| +533% | +$42.1K | ﹤0.01% | 3777 |
|
2022
Q3 | $9K | Sell |
614
-326
| -35% | -$4.78K | ﹤0.01% | 4241 |
|
2022
Q2 | $12K | Buy |
+940
| New | +$12K | ﹤0.01% | 4272 |
|
2021
Q2 | – | Sell |
-777
| Closed | -$15K | – | 4246 |
|
2021
Q1 | $15K | Buy |
+777
| New | +$15K | ﹤0.01% | 3692 |
|